Featured content in this Issue: Companies, organisations and drug candidates mentioned in this Bulletin: Numinus Wellness; The Dales Report; Algernon Pharmaceuticals; AP-188; Seyltx; atai Life Sciences; IBX-210; DMX-1002; Seaport Therapeutics; Karuna; SPT-348; Otsuka; Click Therapeutics; Rejoyn; Lykos Therapeutics. This is the first issue of our Psychedelic Bulletin that’s exclusively…
